November 5, 2026
When a patient is diagnosed with an unruptured brain aneurysm, one of the first questions they ask is whether the pouch will get bigger over time. The short answer is yes: brain aneurysms are dynamic vascular structures, not static defects. Because they exist within a high-pressure, pulsatile circulatory network, some aneurysms slowly enlarge, alter their physical shape, or develop secondary outpouches over months or years.
Documented growth is clinically significant because an enlarging aneurysm carries a substantially higher risk of rupture compared to one that remains stable in size. For this reason, active surveillance—carefully monitoring an aneurysm through serial neuroimaging—is a cornerstone of modern neurovascular care.
A brain aneurysm forms when the structural layers of an arterial wall—specifically the internal elastic lamina and the muscular tunica media—weaken and thin out. Once this structural compromise begins, several mechanical and biological forces can drive further growth:
Not all unruptured aneurysms grow at the same rate. Neurovascular specialists evaluate several distinct anatomical and clinical variables to estimate the likelihood of expansion:
When a small, unruptured aneurysm is identified and determined to have a low immediate risk of rupture, neurosurgeons often recommend a structured surveillance protocol rather than immediate invasive intervention.
Monitoring is performed using non-invasive, high-definition neuroimaging:
Time-of-flight (TOF) MRA is the most common surveillance tool. Because it utilizes magnetic fields rather than ionizing radiation and generally does not require intravenous contrast dye, MRA provides an exceptionally safe, highly detailed method for tracking the 3D geometry of an aneurysm over many years.
CTA uses intravenous contrast and rapid X-ray scanning to generate microscopic, bone-subtracted maps of brain blood vessels. While it involves low-dose radiation and iodinated contrast, CTA is often chosen when an MRA is contraindicated (e.g., in patients with non-compatible pacemakers) or when resolving the spatial relationship between the aneurysm and nearby bony skull base landmarks is necessary.
Catheter-based cerebral angiography is typically not used for routine surveillance. However, if non-invasive scans reveal definitive growth, structural irregularity, or ambiguous changes, a DSA is performed to measure neck-to-dome ratios, evaluate flow dynamics, and map out immediate surgical or endovascular options.
Surveillance protocols are tailored to each patient’s risk profile, but a standard monitoring schedule follows a methodical timeline:
If serial imaging reveals that an aneurysm has increased in diameter—even by just one millimeter—or has developed a new daughter sac, the clinical strategy changes. Measurable enlargement indicates that the structural integrity of the arterial wall is actively degrading, sharply elevating the short-term risk of a subarachnoid hemorrhage.
At this point, the neurovascular team will transition the patient from watchful surveillance to definitive preventive intervention. Depending on the aneurysm’s new dimensions, shape, and location, treatments such as minimally invasive endovascular coiling, flow-diverting stents, or microsurgical clipping are employed to permanently seal the lesion and protect against future rupture.